Provided is a diagnostic drug for evaluating permeability of intestinal mucosa, including chitin and/or chitosan as a main component. The chitin and/or chitosan to be used preferably has a weight average molecular weight prepared to a range of from 1,000 to 11,600.

Oral formulations include anti-viral agents. These oral formulations are manufactured in various permutations such as a chewing gum or lozenge which incorporate anti-viral agents for protecting an individuals body from viruses.

Oral formulations include anti-viral agents. These oral formulations are manufactured in various permutations such as a chewing gum or lozenge which incorporate anti-viral agents for protecting an individuals body from viruses.

The present invention relates to a composition comprising a plurality of silicate nanoparticles; a hydrophilic polymer; and water, and optionally further comprising a thickening polymer; a plurality of zinc oxide particles; a polymer comprising a plurality of quaternary ammonium functional groups; an adhesive polymer; an oil or a polyol. The invention also relates to a use of the composition in prevention and/or treatment of a disease in a mammal, such as skin disease or mastitis. The invention relates further to a sealant of a duct in a body of a mammal comprising said composition.

The present invention relates to a composition comprising a plurality of silicate nanoparticles; a hydrophilic polymer; and water, and optionally further comprising a thickening polymer; a plurality of zinc oxide particles; a polymer comprising a plurality of quaternary ammonium functional groups; an adhesive polymer; an oil or a polyol. The invention also relates to a use of the composition in prevention and/or treatment of a disease in a mammal, such as skin disease or mastitis. The invention relates further to a sealant of a duct in a body of a mammal comprising said composition.

Provided are an adhesion preventing agent and an adhesion preventing method using the same. Specifically, provided are an adhesion preventing agent, including at least one anionized nanomaterial selected from the group consisting of anionized nanocellulose and anionized nanochitin, and an adhesion preventing method using the adhesion preventing agent.

Provided are an adhesion preventing agent and an adhesion preventing method using the same. Specifically, provided are an adhesion preventing agent, including at least one anionized nanomaterial selected from the group consisting of anionized nanocellulose and anionized nanochitin, and an adhesion preventing method using the adhesion preventing agent.

Provided herein are compositions and methods for delivering pharmaceutical agents. In particular, provided herein are hydrogel formulations of suramin for use in wound healing, wound prevention, and other applications.

Provided herein are compositions and methods for delivering pharmaceutical agents. In particular, provided herein are hydrogel formulations of suramin for use in wound healing, wound prevention, and other applications.

Provided is an immunostimulator containing: chitosan and/or a chitosan derivative each having a weight-average molecular weight of 10k to 1000k; and an anionic surfactant, the immunostimulator being in particulate form. Also provided are a pharmaceutical composition and an alimentary product, each containing the immunostimulator as an active ingredient.